US Patent Granted for SoluPro™ Technology

US Patent Granted for SoluPro™ Technology

Vancouver, WA – April 11, 2017 United States Patent No. 9,617,335 was issued today to AbSci, an industry leader in biomanufacturing innovation, for its SoluPro™ protein expression system, which produces complex therapeutic proteins at unparalleled yield and throughput...
AbSci Receives European Patent on its SoluPro™ Expression Platform

AbSci Receives European Patent on its SoluPro™ Expression Platform

AbSci a global leader in biomanufacturing technologies, was granted a European regional patent today for its SoluPro™ protein production technology. “Many years of discovery went into developing the SoluPro™ expression platform. The SoluPro™ technology provides a revolutionary solution to one of biomanufacturing’s ongoing challenges …